Bridging the Scales via Personalized Cellular Modeling and Deep Phenotyping in Schizophrenia - Summary - MDSpire

Bridging the Scales via Personalized Cellular Modeling and Deep Phenotyping in Schizophrenia

  • By

  • Florian J. Raabe

  • David Popovic

  • Clara Vetter

  • Laura E. Fischer

  • Genc Hasanaj

  • Berkhan Karslı

  • Tim J. Schäfer

  • Valeria Almeida

  • Alessia Atella

  • Miriam Gagliardi

  • Emanuel Boudriot

  • Vladislav Yakimov

  • Lucia Trastulla

  • Tengjia Jiang

  • Clara Weyer

  • Lukas Roell

  • Joanna Moussiopoulou

  • Lenka Krčmář

  • Sabrina Galinski

  • Irina Papazova

  • Oliver Pogarell

  • Alkomiet Hasan

  • Eva C. Schulte

  • Andrea Schmitt

  • Nikolaos Koutsouleris

  • Anna Levina

  • Elias Wagner

  • Moritz J. Rossner

  • Sergi Papiol

  • Peter Falkai

  • Daniel Keeser

  • Michael J. Ziller

  • CDP Working Group

  • Stephanie Behrens

  • Man-Hsin Chang

  • Valéria de Almeida

  • Sylvia de Jonge

  • Fanny Dengl

  • Lina Dürrwald

  • Nadja Gabellini

  • Vanessa Gabriel

  • Thomas Geyer

  • Katharina Hanken

  • Alexandra Hisch

  • Georgios Ioannou

  • Marcus Ising

  • Iris Jäger

  • Marcel Kallweit

  • Temmuz Karali

  • Susanne Karch

  • Christoph Kern

  • Nicole L. Klimas

  • Maxim Korman

  • Lenka Krcmar

  • Verena Meisinger

  • Julian Melcher

  • Matin Mortazavi

  • Karin Neumeier

  • Frank Padberg

  • Boris Papazov

  • Pauline Pingen

  • Siegfried G. Priglinger

  • Philipp Sämann

  • Susanne Schmölz

  • Enrico Schulz

  • Benedikt Schworm

  • Sophie Seeburger

  • Sven Wichert

  • Peter Zill

  • May 1, 2026

  • 0 min

Share

Objective:

To integrate molecular, cellular, and systems-level variability to uncover the neurobiological underpinnings of cognitive impairments in schizophrenia (SCZ), emphasizing the importance of this integration.

Key Findings:
  • Identified alternative polyadenylation as a mechanism reducing synaptic density in iPSC-derived neurons in SCZ, highlighting its role in cognitive deficits.
  • Demonstrated significant correlations between cognitive patterns and brain patterns in SCZ individuals, suggesting a link between structure and function.
  • Established links between microscale molecular changes and macro-scale cognitive impairments, underscoring the relevance of iPSC models.
Interpretation:

The study highlights the potential of iPSC technology to bridge genetic, molecular, and cognitive aspects of SCZ, offering insights into personalized interventions and future research directions.

Limitations:
  • Study limited to specific cohorts, which may affect generalizability; further studies are needed to validate findings across diverse populations.
  • Potential confounding factors in cognitive assessments and genetic analyses that could influence results.
Conclusion:

The integration of iPSC models with comprehensive phenotyping provides a promising framework for understanding cognitive deficits in SCZ and developing targeted therapies, emphasizing the need for personalized approaches.

Original Source(s)

Bridging the Scales via Personalized Cellular Modeling and Deep Phenotyping in Schizophrenia

  • by Florian J. Raabe, David Popovic, Clara Vetter, Laura E. Fischer, Genc Hasanaj, Berkhan Karslı, Tim J. Schäfer, Valeria Almeida, Alessia Atella, Miriam Gagliardi, Emanuel Boudriot, Vladislav Yakimov, Lucia Trastulla, Tengjia Jiang, Clara Weyer, Lukas Roell, Joanna Moussiopoulou, Lenka Krčmář, Sabrina Galinski, Irina Papazova, Oliver Pogarell, Alkomiet Hasan, Eva C. Schulte, Andrea Schmitt, Nikolaos Koutsouleris, Anna Levina, Elias Wagner, Moritz J. Rossner, Sergi Papiol, Peter Falkai, Daniel Keeser, Michael J. Ziller, CDP Working Group, Stephanie Behrens, Man-Hsin Chang, Valéria de Almeida, Sylvia de Jonge, Fanny Dengl, Lina Dürrwald, Nadja Gabellini, Vanessa Gabriel, Thomas Geyer, Katharina Hanken, Alexandra Hisch, Georgios Ioannou, Marcus Ising, Iris Jäger, Marcel Kallweit, Temmuz Karali, Susanne Karch, Christoph Kern, Nicole L. Klimas, Maxim Korman, Lenka Krcmar, Verena Meisinger, Julian Melcher, Matin Mortazavi, Karin Neumeier, Frank Padberg, Boris Papazov, Pauline Pingen, Siegfried G. Priglinger, Philipp Sämann, Susanne Schmölz, Enrico Schulz, Benedikt Schworm, Sophie Seeburger, Sven Wichert, Peter Zill

  • May 1, 2026

Related Content

Acceptance of mental illness and attitude towards pharmacotherapy among patients hospitalized in forensic psychiatry departments

Transitioning from Reactive to Proactive Approaches: A Comprehensive Framework for Preventive Psychiatry

SAMHSA Awards $255 Million to Administer 988 Lifeline